Abstract
Objective: Our purpose was to investigate the role of routine utilization of CA-125 in the diagnosis and treatment of recurrent ovarian cancer, with particular attention to surgical outcomes of secondary cytoreductive surgery (SCS).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
